Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 8;22(8):3869.
doi: 10.3390/ijms22083869.

Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy

Affiliations
Review

Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy

Yasuteru Inoue et al. Int J Mol Sci. .

Abstract

Cerebral amyloid angiopathy (CAA) is characterized by accumulation of amyloid β (Aβ) in walls of leptomeningeal vessels and cortical capillaries in the brain. The loss of integrity of these vessels caused by cerebrovascular Aβ deposits results in fragile vessels and lobar intracerebral hemorrhages. CAA also manifests with progressive cognitive impairment or transient focal neurological symptoms. Although development of therapeutics for CAA is urgently needed, the pathogenesis of CAA remains to be fully elucidated. In this review, we summarize the epidemiology, pathology, clinical and radiological features, and perspectives for future research directions in CAA therapeutics. Recent advances in mass spectrometric methodology combined with vascular isolation techniques have aided understanding of the cerebrovascular proteome. In this paper, we describe several potential key CAA-associated molecules that have been identified by proteomic analyses (apolipoprotein E, clusterin, SRPX1 (sushi repeat-containing protein X-linked 1), TIMP3 (tissue inhibitor of metalloproteinases 3), and HTRA1 (HtrA serine peptidase 1)), and their pivotal roles in Aβ cytotoxicity, Aβ fibril formation, and vessel wall remodeling. Understanding the interactions between cerebrovascular Aβ deposits and molecules that accumulate with Aβ may lead to discovery of effective CAA therapeutics and to the identification of biomarkers for early diagnosis.

Keywords: amyloid β; cerebral amyloid angiopathy; cerebral microbleeds; intracerebral hemorrhage; proteomic analyses; superficial siderosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Histopathological and radiological imaging of CAA (cerebral amyloid angiopathy). Representative histopathological images from a patient with severe CAA. Congo red-positive leptomeningeal arteries (A) and those same arteries viewed under polarized light (B). SWI (susceptibility-weighted imaging) MRI shows a strictly lobar distribution of lobar microbleeds (arrowheads) (C). SWI shows cSS (cortical superficial siderosis) as hypointense curvilinear signals along the cortical gyri (arrows) (D). Scale bars = 1 mm.

References

    1. Viswanathan A., Greenberg S.M. Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 2011;70:871–880. doi: 10.1002/ana.22516. - DOI - PMC - PubMed
    1. Keage H.A., Carare R.O., Friedland R.P., Ince P.G., Love S., Nicoll J.A., Wharton S.B., Weller R.O., Brayne C. Population studies of sporadic cerebral amyloid angiopathy and dementia: A systematic review. BMC Neurol. 2009;9:3. doi: 10.1186/1471-2377-9-3. - DOI - PMC - PubMed
    1. Xuereb J.H., Brayne C., Dufouil C., Gertz H., Wischik C., Harrington C., Mukaetova-Ladinska E., McGee M.A., O’Sullivan A., O’Connor D., et al. Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann. N. Y. Acad. Sci. 2000;903:490–496. doi: 10.1111/j.1749-6632.2000.tb06404.x. - DOI - PubMed
    1. Neuropathology Group: Medical Research Council Cognitive Function and Aging Study Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) Lancet. 2001;357:169–175. doi: 10.1016/S0140-6736(00)03589-3. - DOI - PubMed
    1. Tanskanen M., Lindsberg P.J., Tienari P.J., Polvikoski T., Sulkava R., Verkkoniemi A., Rastas S., Paetau A., Kiuru-Enari S. Cerebral amyloid angiopathy in a 95+ cohort: Complement activation and apolipoprotein E (ApoE) genotype. Neuropathol. Appl. Neurobiol. 2005;31:589–599. doi: 10.1111/j.1365-2990.2005.00652.x. - DOI - PubMed